These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 837968)

  • 1. Fluorometric determination of hydroflumethiazide in human plasma and urine after its oral administration.
    Brors O; Jacobsen S; Arnesen E
    Eur J Clin Pharmacol; 1977 Jan; 11(2):149-54. PubMed ID: 837968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrofluorometric determination of hydroflumethiazide in plasma and urine.
    Smith RB; Smith RV; Yakatan GJ
    J Pharm Sci; 1976 Aug; 65(8):1208-11. PubMed ID: 10417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of elimination of hydroflumethiazide in man.
    Brørs O; Jacobsen S
    Eur J Clin Pharmacol; 1979 Sep; 16(2):125-31. PubMed ID: 499309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of hydroflumethiazide during repeated administration in congestive heart failure.
    Brørs O
    Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):177-81. PubMed ID: 7136723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of orally administered hydroflumethiazide in man.
    Yakatan GJ; Smith RB; Frome EL; Doluisio JT
    J Clin Pharmacol; 1977 Jan; 17(1):37-47. PubMed ID: 833338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excretion of hydroflumethiazide in bile and urine of man.
    Brørs O; Haffner JF; Jacobsen S
    Eur J Clin Pharmacol; 1979 May; 15(4):287-9. PubMed ID: 477714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative fluorometric TLC procedure for determination of hydroflumethiazide in biological fluids,
    Garceau Y; Davis I; Hasegawa J
    J Pharm Sci; 1974 Nov; 63(11):1793-5. PubMed ID: 4427251
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of hydroflumethiazide during repeated oral administration to healthy subjects.
    Brørs O; Jacobsen S
    Eur J Clin Pharmacol; 1979 May; 15(4):281-6. PubMed ID: 477713
    [No Abstract]   [Full Text] [Related]  

  • 9. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.
    Jufer RA; Wstadik A; Walsh SL; Levine BS; Cone EJ
    J Anal Toxicol; 2000 Oct; 24(7):467-77. PubMed ID: 11043648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption kinetics of hydroflumethiazide.
    McNamara PJ; Colburn WA; Gibaldi M
    J Clin Pharmacol; 1978 Apr; 18(4):190-3. PubMed ID: 632365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
    Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
    Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a single oral dose of hydroflumethiazide in health and in cardiac failure.-.
    Brørs O; Jacobsen S; Arnesen E
    Eur J Clin Pharmacol; 1978 Nov; 14(1):29-37. PubMed ID: 729604
    [No Abstract]   [Full Text] [Related]  

  • 16. Separation and quantitative determination of 2,4-disulfamyl-5-trifluoromethylaniline in hydroflumethiazide using high-pressure liquid chromatography.
    Owen BJ; Wilkie SV
    J Pharm Sci; 1977 Jun; 66(6):877-8. PubMed ID: 874795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatran.
    Eriksson UG; Johansson S; Attman PO; Mulec H; Frison L; Fager G; Samuelsson O
    Clin Pharmacokinet; 2003; 42(8):743-53. PubMed ID: 12846595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
    Rohatagi S; Shah B; Zhang J; Zeng Z; Kirkesseli S; Jensen BK
    J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
    Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
    Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.